Two Sigma Advisers
ELOS

Two Sigma Advisers’s Syneron Medical Ltd ELOS Stock Holding History

Two Sigma Advisers’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-78,236
Closed -$857K – 2461
2017
Q2 		$857K Sell
78,236
-216,706
-73% -$2.38M ﹤0.01% 1591
2017
Q1 		$3.11M Buy
294,942
+146,042
+98% +$1.41M 0.01% 1035
2016
Q4 		$1.25M Buy
148,900
+50,900
+52% +$399K ﹤0.01% 1445
2016
Q3 		$702K Buy
98,000
+29,900
+44% +$208K ﹤0.01% 1515
2016
Q2 		$524K Sell
68,100
-15,700
-19% -$112K ﹤0.01% 1492
2016
Q1 		$613K Sell
83,800
-16,300
-16% -$117K ﹤0.01% 1372
2015
Q4 		$772K Sell
100,100
-5,600
-5% -$42.7K ﹤0.01% 1144
2015
Q3 		$803K Sell
105,700
-35,800
-25% -$344K 0.01% 1103
2015
Q2 		$1.5M Sell
141,500
-55,200
-28% -$646K 0.01% 929
2015
Q1 		$2.44M Buy
196,700
+140,500
+250% +$1.56M 0.02% 700
2014
Q4 		$524K Sell
56,200
-1,500
-3% -$14.5K ﹤0.01% 1590
2014
Q3 		$578K Buy
57,700
+1,200
+2% +$12.2K ﹤0.01% 1453
2014
Q2 		$583K Sell
56,500
-7,400
-12% -$80K ﹤0.01% 1560
2014
Q1 		$795K Buy
63,900
+32,600
+104% +$386K 0.01% 1284
2013
Q4 		$385K Buy
31,300
+4,000
+15% +$41.6K ﹤0.01% 1762
2013
Q3 		$236K Sell
27,300
-6,100
-18% -$52.6K ﹤0.01% 1830
2013
Q2 		$292K Buy
+33,400
New +$299K ﹤0.01% 1733

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Two Sigma Advisers's ELOS Position: Q3 2017 in Review

Two Sigma Advisers sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 78,236 shares — an estimated $857K sold.

Two Sigma Advisers first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $3.11M in Q1 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Two Sigma Advisers reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Two Sigma Advisers sold 78,236 Syneron Medical Ltd shares in Q3 2017, an estimated $857K.
  • Two Sigma Advisers first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Two Sigma Advisers's Syneron Medical Ltd position peaked at $3.11M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Two Sigma Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.